ArticleOcular oncology and pathology2026
Reproducibility of Perfusion-Weighted and Diffusion-Weighted Magnetic Resonance Imaging in Patients with Ocular Tumours.
Article in Ocular oncology and pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Diffusion-weighted imaging (DWI) and perfusion-weighted imaging (PWI) can assess biological tumour characteristics of uveal melanoma (UM), the most common primary intraocular malignant tumour in adults. Recent studies propose that these techniques can aid in the differential diagnosis, provide prognostic information, and enable early assessment of treatment response following radiation therapy. However, it is important to determine the extent to which any observed differences can be attributable to true biological changes in the tumour rather than day-to-day physiological or measurement variations. Therefore, this study aimed to assess the reproducibility of ocular DWI and PWI measurements between two centres. Method: In this prospective study, 15 patients with UM were included. Each patient underwent two MRIs at two different centres with a mean interval of 28 days (range: 12-43 days). Apparent diffusion coefficient (ADC), relative peak intensity, and outflow percentage of the tumour were compared between the two timepoints. Mean absolute differences between the two timepoints were calculated. Results: Mean absolute differences between the two timepoints were 0.07 × 10 Conclusion: This study shows that DWI and PWI parameters demonstrate reproducibility in UM patients between two different centres, with variabilities smaller than differences typically observed in differential diagnosis or treatment response assessments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.